Overview
Kyasanur Forest disease (KFD) is a tick-borne viral zoonosis initially endemic to the Western Ghats region of Karnataka, India, but has since spread to other areas. There is currently no effective treatment, highlighting the urgent need for vaccine development 1.Diagnosis
Clinical presentation includes fever, headache, myalgia, and hemorrhagic manifestations.
Laboratory diagnosis involves serological tests such as ELISA and RT-PCR for KFD virus detection 1.Management
No specific antiviral treatments are currently available; management is primarily supportive 1.
Supportive care includes hydration, pain management, and monitoring for complications like encephalitis 1.Special Populations
No specific guidelines provided in the abstracts regarding pregnancy, pediatrics, elderly, or comorbidities 1.Key Recommendations
Develop and evaluate multi-epitope vaccine candidates targeting KFDV envelope protein epitopes for potential future prevention strategies (Evidence: Expert opinion) 1.
Implement rigorous surveillance and reporting systems to monitor the spread of KFD beyond endemic regions (Evidence: Expert opinion) 1.
Continue research into immunoinformatics approaches for identifying stable and safe vaccine components interacting with immune receptors (Evidence: Expert opinion) 1.References
1 Kasibhatla SM, Rajan L, Shete A, Jani V, Yadav S, Joshi Y et al.. Construction of an immunoinformatics-based multi-epitope vaccine candidate targeting Kyasanur forest disease virus. PeerJ 2025. link